These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21458577)

  • 1. Peroxisome proliferator activated receptor alpha activation decreases inflammatory and destructive responses in osteoarthritic cartilage.
    Clockaerts S; Bastiaansen-Jenniskens YM; Feijt C; Verhaar JA; Somville J; De Clerck LS; Van Osch GJ
    Osteoarthritis Cartilage; 2011 Jul; 19(7):895-902. PubMed ID: 21458577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
    Tchetina EV; Di Battista JA; Zukor DJ; Antoniou J; Poole AR
    Arthritis Res Ther; 2007; 9(4):R75. PubMed ID: 17683641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1β and inhibited by peroxisome proliferator activated receptor α agonist.
    Clockaerts S; Bastiaansen-Jenniskens YM; Feijt C; De Clerck L; Verhaar JA; Zuurmond AM; Stojanovic-Susulic V; Somville J; Kloppenburg M; van Osch GJ
    Ann Rheum Dis; 2012 Jun; 71(6):1012-8. PubMed ID: 22307941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage.
    Bastiaansen-Jenniskens YM; Clockaerts S; Feijt C; Zuurmond AM; Stojanovic-Susulic V; Bridts C; de Clerck L; DeGroot J; Verhaar JA; Kloppenburg M; van Osch GJ
    Ann Rheum Dis; 2012 Feb; 71(2):288-94. PubMed ID: 21998115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroprotective and anti-inflammatory effects of S-methylisothiourea, an inducible nitric oxide synthase inhibitor in cartilage and synovial explants model of osteoarthritis.
    Balaganur V; Pathak NN; Lingaraju MC; More AS; Latief N; Kumari RR; Kumar D; Tandan SK
    J Pharm Pharmacol; 2014 Jul; 66(7):1021-31. PubMed ID: 24697299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions.
    Chan PS; Caron JP; Orth MW
    Am J Vet Res; 2007 Jul; 68(7):709-15. PubMed ID: 17605605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture.
    van Buul GM; Villafuertes E; Bos PK; Waarsing JH; Kops N; Narcisi R; Weinans H; Verhaar JA; Bernsen MR; van Osch GJ
    Osteoarthritis Cartilage; 2012 Oct; 20(10):1186-96. PubMed ID: 22771777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-α Agonist WY-14643 Inhibits LPS-Induced Inflammation in Synovial Fibroblasts via NF-kB Pathway.
    Huang D; Zhao Q; Liu H; Guo Y; Xu H
    J Mol Neurosci; 2016 Aug; 59(4):544-53. PubMed ID: 27339772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
    Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
    Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glatiramer acetate (GA), the immunomodulatory drug, inhibits inflammatory mediators and collagen degradation in osteoarthritis (OA) cartilage.
    Attur M; Millman JS; Dave MN; Al-Mussawir HE; Patel J; Palmer G; Abramson SB
    Osteoarthritis Cartilage; 2011 Sep; 19(9):1158-64. PubMed ID: 21745583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrogen sulfide sources on inflammation and catabolic markers on interleukin 1β-stimulated human articular chondrocytes.
    Burguera EF; Vela-Anero A; Magalhães J; Meijide-Faílde R; Blanco FJ
    Osteoarthritis Cartilage; 2014 Jul; 22(7):1026-35. PubMed ID: 24831018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants.
    Uitterlinden EJ; Jahr H; Koevoet JL; Jenniskens YM; Bierma-Zeinstra SM; Degroot J; Verhaar JA; Weinans H; van Osch GJ
    Osteoarthritis Cartilage; 2006 Mar; 14(3):250-7. PubMed ID: 16300972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.
    Wilkinson DJ; Wang H; Habgood A; Lamb HK; Thompson P; Hawkins AR; Désilets A; Leduc R; Steinmetzer T; Hammami M; Lee MS; Craik CS; Watson S; Lin H; Milner JM; Rowan AD
    Arthritis Rheumatol; 2017 Aug; 69(8):1601-1611. PubMed ID: 28464560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
    Stevens AL; Wheeler CA; Tannenbaum SR; Grodzinsky AJ
    Osteoarthritis Cartilage; 2008 Apr; 16(4):489-97. PubMed ID: 17923423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
    Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
    Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.
    Wang X; Li F; Fan C; Wang C; Ruan H
    Int J Mol Med; 2011 Apr; 27(4):583-9. PubMed ID: 21305249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.